Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoral Products Regulatory News (CRU)

Share Price Information for Coral Products (CRU)

Share Price is delayed by 15 minutes
Get Live Data
5.625    0.00 (0.00%)
Bid:
5.50
Ask:
5.75
Spread: 0.25 (4.545%)
Market Cap: £5.00m
CRU Live PriceLast checked at - London Stock Exchange

Intraday Coral Products Share Chart

Share Buyback Programme

10 Jul 2023 11:36

RNS Number : 5159F
Coral Products PLC
10 July 2023
 

10 July 2023

 

Coral Products Plc

("CRU" or the "Company")

 

Share Buyback Programme

 

 

Coral Products PLC, a specialist in the design, manufacture and supply of injection moulded plastic products based in Wythenshawe, Manchester announces that the Board has approved the terms of a share buyback programme (the "Programme") to buy back the Company's ordinary shares of 1 pence each (the "Ordinary Shares") up to £500,000. The Company intends to conduct the Programme up to the earlier of the Company's next annual general meeting ("AGM") or 31st October 2023. However, the Board will keep the form and quantum of the Programme under review while allowing the Company to maintain its current dividend policy. The Programme will be funded from the Company's current cash balances.

 

The Company will seek to make market purchases at a price or prices that the Company believes will be value-enhancing for shareholders and limits the maximum number of Ordinary Shares CRU can buy back to 3,000,000.

 

The Company will hold as treasury shares any Ordinary Shares repurchased in accordance with the provisions of the Companies Act 2006. Ordinary Shares held in treasury are not entitled to dividends and have no voting rights at the Company's general meetings. The Company will make further regulatory announcements in respect of repurchases of Ordinary Shares as required by UK MAR and the AIM Rules.

The Programme will be executed within the limitations of the shareholder authority granted at the AGM held on 29 September 2022, under which the minimum price which may be paid by the Company is 1 pence per Ordinary Share, and the maximum price which may be paid for an ordinary share exclusive of expenses is equal to the higher of (i) 105 per cent of the average of the middle market quotations for an ordinary share derived from the London Stock Exchange Daily Official List for the five business days immediately preceding the day on which the purchase is made and (ii) the higher of (a) the price of the last independent trade and (b) the highest current independent bid (in each case, in relation to (a) and (b), for any number of the Company's ordinary shares on the trading venue where the purchase is carried out).

Notwithstanding the average daily volume restrictions set out in Article 3(3) (b) of the Commission Delegated Regulation (EU) 2016/1052, the Company expects to make purchases in excess of these volume restrictions, subject to prevailing market conditions and liquidity.

Certain of the information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the UK version of the EU Market Abuse Regulation (2014/596) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended and supplemented from time to time.

For further information, please contact:

 

Coral Products plc

Joe Grimmond, Chairman

 

 

Tel: 07703 518 148

 

Nominated Adviser & Broker

Cenkos LLP

Adrian Hadden

Charlie Combe

 

Tel: 020 7397 1966

Financial PR

Novella

Tim Robertson

Tel: 020 3151 7008

 

This announcement has been posted to: https://coralproducts.com/

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSURORROSUBAAR
Date   Source Headline
20th Apr 20264:15 pmRNSDirector/PDMR Shareholding
20th Apr 202612:20 pmRNSTrading Update
16th Feb 20267:00 amRNSAcquisition of the assets of AAC Cyroma Limited
8th Jan 20267:00 amRNSHalf-year Financial Report
26th Nov 20254:45 pmRNSResult of AGM & Directorate Change
26th Nov 20257:00 amRNSAGM Statement
31st Oct 202512:00 pmRNSNotice of AGM and Posting of Annual Report
31st Oct 20257:00 amRNSFinal Results
28th Aug 20253:50 pmRNSTransaction in Own Shares
26th Aug 20257:00 amRNSTransaction in Own Shares
22nd Aug 20257:00 amRNSTransaction in Own Shares
10th Jul 20258:58 amRNSDirectorate Change
8th Jul 202510:08 amRNSIssue of Options
7th Jul 202510:08 amRNSFull Year Trading Update and Acquisition Update
30th May 20257:00 amRNSDirector/PDMR Shareholding
6th May 20257:00 amRNSDirectorate Change
4th Apr 20253:36 pmRNSDirector/PDMR Shareholding
3rd Apr 20252:15 pmRNSDirector/PDMR Shareholding
1st Apr 20253:50 pmRNSAcquisition of the assets of Arrow Film Converters
20th Mar 202511:00 amRNSIce Cream & Food Container three-year Agreement
4th Mar 20257:00 amRNSRenewal of Contract
27th Feb 202512:57 pmRNSDirector/PDMR Shareholding
26th Feb 202511:07 amRNSDirector/PDMR Shareholding
21st Feb 202511:02 amRNSDirector/PDMR Shareholding
17th Feb 20257:00 amRNSCompletion of Property Sale and Directorate Change
3rd Feb 20257:00 amRNSChange of Adviser
28th Jan 20254:35 pmRNSDirector/PDMR Shareholding
27th Jan 20257:00 amRNSHalf-year Report
7th Jan 20257:00 amRNSProperty Sales and Insurance Claim Settlement
4th Dec 20247:00 amRNSDirectorate Change
12th Nov 20247:00 amRNSDirectorate Change
25th Oct 20247:00 amRNSDirectorate Change
23rd Oct 20244:30 pmRNSResult of General Meeting
14th Oct 20247:00 amRNSTrading Statement
17th Sep 20247:00 amRNSFinal Results
24th Jul 20247:00 amRNSSale and Leaseback of Runcorn Factory Site
11th Jun 20247:00 amRNSTrading Statement
23rd May 20245:45 pmRNSTransaction in Own Shares
23rd May 20247:00 amRNSDirector/PDMR Shareholding
22nd May 20246:20 pmRNSTransaction in Own Shares
13th May 20244:30 pmRNSDirector/PDMR Shareholding
9th May 20242:50 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSDirector/PDMR Shareholding
26th Jan 20247:00 amRNSTrading Statement
11th Dec 20237:00 amRNSHalf-year Report
29th Nov 20237:00 amRNSTrading Update and Directorate Change
7th Nov 20237:00 amRNSChange of Nominated Adviser and Broker
13th Oct 20235:21 pmRNSTransaction in Own Shares
12th Oct 20235:22 pmRNSTransaction in Own Shares
11th Oct 20235:52 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.